VEBINOVE Trademark

Trademark Overview

On Tuesday, June 23, 2015, a trademark application was filed for VEBINOVE with the United States Patent and Trademark Office. The USPTO has given the VEBINOVE trademark a serial number of 86671106. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 1, 2019. This trademark is owned by Pfizer Inc.. The VEBINOVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
vebinove

General Information

Serial Number86671106
Word MarkVEBINOVE
Filing DateTuesday, June 23, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
Translation of Words in MarkThe wording "VEBINOVE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 30, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, July 1, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 1, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 22, 2018EXTENSION 5 GRANTED
Thursday, October 11, 2018EXTENSION 5 FILED
Thursday, October 18, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 11, 2018TEAS EXTENSION RECEIVED
Tuesday, May 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 27, 2018EXTENSION 4 GRANTED
Friday, April 27, 2018EXTENSION 4 FILED
Friday, April 27, 2018TEAS EXTENSION RECEIVED
Saturday, October 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 12, 2017EXTENSION 3 GRANTED
Thursday, October 12, 2017EXTENSION 3 FILED
Thursday, October 12, 2017TEAS EXTENSION RECEIVED
Saturday, April 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 5, 2017EXTENSION 2 GRANTED
Wednesday, April 5, 2017EXTENSION 2 FILED
Wednesday, April 5, 2017TEAS EXTENSION RECEIVED
Friday, September 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2016EXTENSION 1 GRANTED
Wednesday, September 14, 2016EXTENSION 1 FILED
Wednesday, September 14, 2016TEAS EXTENSION RECEIVED
Tuesday, May 31, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, March 2, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, September 24, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 24, 2015NON-FINAL ACTION E-MAILED
Thursday, September 24, 2015NON-FINAL ACTION WRITTEN
Wednesday, September 23, 2015ASSIGNED TO EXAMINER
Tuesday, June 30, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 26, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

vebinove preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases